483 CSPC Ouyi Pharmaceutical Aug 2017

483 CSPC Ouyi Pharmaceutical Aug 2017

Christopher Middendorf FDA$119.00 - Available Now

FDA investigators audited the CSPC Ouyi Pharmaceutical - Shijiazhuang, China facility and issued inspectional observations (via FDA 483) on 02 Aug 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 02 Aug 2017
  • Location: Shijiazhuang, China
  • FEI: 2000021110
Add To Cart